The Lancet Breast Cancer Commission

The Lancet Breast Cancer Commission—a diverse, multidisciplinary international group—are unanimous in our determination to improve the lives of all people who live with or are at risk of breast cancer. We came together in July, 2021, and are committed to raising the standard of breast cancer care to close the equity gap that exists between and within countries. Over a 2-year period, we brainstormed ideas, scoped the literature, obtained funding for dedicated pilot research that provided new data, and produced this Commission report to reduce the effects that breast cancer has on society. The role of racial and ethnic discrimination in breast cancer disparitiesThe Lancet Breast Cancer Commission report encompasses prevention, personalised treatment, inclusive management of metastatic breast cancer, identifying the hidden costs of breast cancer, tackling breast cancer gaps and inequities through global collaboration, and communication and empowerment.1 It is also important to recognise and address discrimination as a key determinant of breast cancer disparities. Here we elucidate mechanisms through which racial and ethnic discrimination affects breast cancer outcomes, and provide a few promising examples to address discrimination via the implementation of anti-discrimination health-care policies and interventions and the mobilisation of minority groups. Full-Text PDF